American Journal of Kidney Diseases
Volume 53, Issue 4, Supplement 4 , Pages S11-S21 , April 2009

Diabetes Mellitus and CKD Awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)

  • Adam Whaley-Connell, DO, MSPH

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S. Truman VA Medical Center, Columbia, MO
    • Corresponding Author InformationAddress correspondence to Adam Whaley-Connell, DO, MSPH, University of Missouri-Columbia School of Medicine, Department of Internal Medicine, Division of Nephrology, MA436, DC043.0, One Hospital Dr, Columbia, MO 65212
    • ,
  • James R. Sowers, MD

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S. Truman VA Medical Center, Columbia, MO
    • ,
  • Peter A. McCullough, MD, MPH

      Affiliations

    • William Beaumont Hospital, Royal Oak, MI
    • ,
  • Tricia Roberts, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Samy I. McFarlane, MD, MPH

      Affiliations

    • SUNY Downstate, Brooklyn, NY
    • ,
  • Shu-Cheng Chen, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Suying Li, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Changchun Wang, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Allan J. Collins, MD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • George L. Bakris, MD

      Affiliations

    • University of Chicago School of Medicine, Chicago, IL
    • ,
  • KEEP Investigators

Received 17 October 2008 ,Accepted 10 January 2009.

References 

  1. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(suppl 2):S12–S154
  2. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  3. Fox CS, Larson MG, Leip EP, et al. Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care. 2005;28:2436–2440
  4. Bianchi C, Miccoli R, Penno G, et al. Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care. 2008;31(suppl 2):S208–S214
  5. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–174
  6. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–2140
  7. Lea J, Cheek D, Thornley-Brown D, et al. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis. 2008;51:732–740
  8. Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis. 2008;51:21–28
  9. Whaley-Connell A, Pavey BS, Afroze A, et al. Obesity and insulin resistance as risk factors for chronic kidney disease. J Cardiometab Syndr. 2006;1:209–214
  10. Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int. 2001;59:702–709
  11. Fioretto P, Bruseghin M, Berto I, et al. Renal protection in diabetes: Role of glycemic control. J Am Soc Nephrol. 2006;17(suppl 2):S86–S89
  12. Menon V, Greene T, Pereira AA, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol. 2005;16:3411–3417
  13. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  14. Cleveland DR, Jindal KK, Hirsch DJ, et al. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis. 2002;40:30–36
  15. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42:22–35
  16. Brown WW, Collins A, Chen SC, et al. Identification of persons at high risk for kidney disease via targeted screening: The NKF Kidney Early Evaluation Program. Kidney Int Suppl. 2003;83:S50–S55
  17. Jurkovitz CT, Qiu Y, Wang C, et al. The Kidney Early Evaluation Program (KEEP): Program design and demographic characteristics of the population. Am J Kidney Dis. 2008;51(suppl 2):S3–S12
  18. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  19. Stevens LA, Stoycheff N. Standardization of serum creatinine and estimated glomerular filtration rate in the National Kidney Foundation Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008;51(suppl 2):S77–S82
  20. National Kidney Foundation. What Is the Kidney Early Evaluation Program (KEEP)?. http://www.kidney.org/news/keep/KEEPabout.cfmAccessed January 7, 2009
  21. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572
  22. Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121:332–340
  23. Saab G, Whaley-Connell AT, McCullough PA, et al. CKD awareness in the United States: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008;52:382–383
  24. McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007;167:1122–1129
  25. Whaley-Connell AT, Sowers JR, McFarlane SI, et al. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(suppl 2):S21–S29
  26. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469–477
  27. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  28. McGill JB, Brown WW, Chen SC, et al. Kidney Early Evaluation Program (KEEP) Findings from a community screening program. Diabetes Educ. 2004;30:196–206
  29. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2003;42(suppl 4):S3–S60
  30. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2005;45(suppl 2):S1–S136
  31. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2005;46(suppl 3):S1–S158
  32. National Kidney Foundation. Kidney Early Evaluation Program Annual Data Report. Am J Kidney Dis. 2007;49(suppl 3):S1–S160
  33. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States (2003. Department of Health and Human Services). http://www.cdc.gov/diabetes/pubs/factsheet.htmAccessed January 7, 2009
  34. US Department of Health and Human Services. Healthy People 2010, Diabetes Progress Review 2002. Washington, DC: US Government Printing Office; 2002;
  35. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  36. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853

PII: S0272-6386(09)00035-3

doi: 10.1053/j.ajkd.2009.01.004

American Journal of Kidney Diseases
Volume 53, Issue 4, Supplement 4 , Pages S11-S21 , April 2009

Article Tools